Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tisbury Pharmaceuticals
AddedFeb 17, 2024
UpdatedJun 18, 2026
Tisbury Pharmaceuticals

Tisbury Pharmaceuticals

Tisbury Pharmaceuticals: Innovating glaucoma therapies, serving Massachusetts.

HQ
Beverly, MA, US
Founded
2017
Overview
Compare
Fundraising
Employees

Tisbury Pharmaceuticals is dedicated to developing and discovering therapies for primary open angle glaucoma. The company aims to innovate in the field of ophthalmology, focusing on providing effective treatments for patients. Tisbury Pharmaceuticals primarily serves the Massachusetts market.

Tisbury Pharmaceuticals has made significant strides in glaucoma therapy, contributing to advancements in eye care. The company's impact is notable in the Massachusetts healthcare sector, where it continues to support patients with cutting-edge treatments.

Tisbury Pharmaceuticals - Similar Companies

Tisento Therapeutics logo

Tisento Therapeutics

Tarsus Pharmaceuticals logo

Tarsus Pharmaceuticals

tarsusrx.com

Tigris Pharmaceuticals logo

Tigris Pharmaceuticals

tigrispharma.com

EyePoint logo

EyePoint

TearClear logo

TearClear

tearclear.com

XTuit Pharmaceuticals logo

XTuit Pharmaceuticals

Tioga Pharmaceuticals logo

Tioga Pharmaceuticals

ISI Life Sciences logo

ISI Life Sciences

Tris Pharma logo

Tris Pharma

trispharma.com

Tremeau Pharmaceuticals logo

Tremeau Pharmaceuticals

Accuitis logo

Accuitis

accuitis.com

Iacta Pharmaceuticals logo

Iacta Pharmaceuticals

Surface Pharmaceuticals logo

Surface Pharmaceuticals

surfacepharma.com

Ocumension Therapeutics logo

Ocumension Therapeutics

Forsight Vision6 logo

Forsight Vision6

Tisbury Pharmaceuticals - Quick Facts

Who are Tisbury Pharmaceuticals' competitors?

Companies similar to Tisbury Pharmaceuticals include Tisento Therapeutics, Tarsus Pharmaceuticals, Tigris Pharmaceuticals and EyePoint.

When was Tisbury Pharmaceuticals founded?

Tisbury Pharmaceuticals was founded in 2017.

Where is Tisbury Pharmaceuticals' headquarters located?

Tisbury Pharmaceuticals' headquarters is located in Beverly, MA, US.

When was Tisbury Pharmaceuticals' last funding round?

Tisbury Pharmaceuticals' most recent funding round was for $32M (USD) in June 2017.

How much has Tisbury Pharmaceuticals raised to-date?

As of Jun 7, 2017, Tisbury Pharmaceuticals has raised a total of $32M (USD).

How many employees does Tisbury Pharmaceuticals have?

Tisbury Pharmaceuticals has 30 employees as of Feb 4, 2024.

Tisbury Pharmaceuticals - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified